Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

ARCHITECT DHEA-S Reagent Product Usage: It is a chemiluminescent microparticle Recalled by Abbott Gmbh & Co. KG Due to Falsely elevated results may be obtained when using...

Date: December 14, 2017
Company: Abbott Gmbh & Co. KG
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Abbott Gmbh & Co. KG directly.

Affected Products

ARCHITECT DHEA-S Reagent Product Usage: It is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of dehydroepiandrosterone sulfate (DHEA-S) in human serum and plasma on the ARCHITECT iSystem.

Quantity: 10,153 units

Why Was This Recalled?

Falsely elevated results may be obtained when using the ARCHITECT DHEA-S assay with samples from infants up to 60 days old.

Where Was This Sold?

This product was distributed to 30 states: AL, AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, LA, MA, MN, MS, MO, NJ, NY, NC, OH, OK, PA, SC, SD, TN, TX, UT, VT, WA, WY

Affected (30 states)Not affected

About Abbott Gmbh & Co. KG

Abbott Gmbh & Co. KG has 18 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report